Gestational Timing Framework
The overarching thesis — for JJ
One pathway. Every gestational week mapped. Every “idiopathic” condition explained.
The damage happens months before birth. The symptoms appear years later — not because anything new goes wrong, but because the brain finally tries to use tracts that were never properly myelinated.
Organ Vulnerability Windows
Fifteen organ systems build during gestation. Each has a window. When that window closes, what wasn’t built stays unbuilt — forever.
| System | Vulnerable Cell | Window | Peak | Regeneration |
|---|---|---|---|---|
| White matter | Pre-oligodendrocytes | 23–36 wk | 24–32 | Proliferative but maturation-arrested |
| Renal | Six2+ cap mesenchyme | 5–36 wk | 20–36 | ZERO — no new nephrons ever |
| Cardiac (septation) | Cardiac neural crest | 3–8 wk | 3–8 | Structural defects are immediate |
| Cardiac (myocytes) | Fetal cardiomyocytes | 8–birth | 20–38 | ~1%/yr adult renewal |
| Hippocampal | CA1 pyramidal neurons | 10–postnatal | 22–36 | Minimal |
| Cerebellar | Purkinje cells | 5–1 yr postnatal | 24–36 | ZERO — Purkinje cells cannot be replaced |
| Immune | DP thymocytes | 6–ongoing | 12–36 | Continuous but declining |
| Pancreatic | β-cell progenitors | 4–infancy | 20–38 | Low renewal |
| Pulmonary | Alveolar type II cells | 16–3 yr postnatal | 24–36 | Partial |
| Cortical (subplate) | Subplate neurons | 13–32 wk | 23–32 | ZERO — transient population, loss is permanent |
| Retinal | Retinal ganglion cells | 6–36 wk | 14–32 | None for RGCs |
| Autonomic (sympathetic) | Sympathetic neurons | 5–34 wk | 20–34 | None |
| Autonomic (brainstem) | 5-HT neurons | 5–36 wk | 20–36 | None |
The Super-Window — Weeks 24–34
At gestational week 28, all ten organ systems are simultaneously at peak vulnerability. Week 28 is Ground Zero.
What converges at week 28
- Maximum organ vulnerability — 9–10 systems in construction phase
- Maximum PHD counter-regulatory load — managing HIF across more tissues than any other time
- Maximum fetal iron demand — cofactor availability may be limiting PHD function
- HIF isoform complexity — all three isoforms active (HIF-1α, HIF-2α, HIF-3α)
- EOPE expressing clinical symptoms — placental insufficiency producing episodic hypoxia
- Autonomic convergent vulnerability — all three autonomic systems at peak (SIDS risk)
- Paternal germline consolidation window active
A single hypoxic event at week 28 produces:
| Outcome | Visible at |
|---|---|
| Speech delay | 3 years |
| Motor deficit | 5 years |
| Learning disability | 7 years |
| Anxiety disorder | 12 years |
| Hypertension | 35 years |
| Metabolic syndrome | 45 years |
None of these are “new” injuries. They are existing damage, unmasked when the brain finally demands a tract that was never built.
Growing Into Deficit
The hallmark of the model. Damage is present at birth but silent — because the white matter tracts it affects aren’t needed yet.
Demand Spike Timeline
When latent injury becomes visible — mapped from birth through old age.
| Age | Demand Spike | Clinical Presentation | System |
|---|---|---|---|
| Birth | Respiratory transition | Respiratory distress, apnoea | Pulmonary, Autonomic |
| 2–4 mo | Autonomic maturation peak | SIDS risk peak | Autonomic |
| 6–18 mo | Motor milestones | Motor delay, hypotonia | WM (CST), Cerebellar |
| 12–24 mo | Regression window | Social withdrawal, gaze decline | WM (multiple) |
| 18–36 mo | Language demand spike | Language delay, loss of words — the hallmark ASD regression | WM (AF, SLF) |
| 2–5 yr | Social cognition | Social deficits, rigid behaviour | WM (cingulum, UF) |
| 5–7 yr | Academic learning | Learning disabilities, dyslexia | WM (AF, ILF, CC) |
| ~7 yr | Sustained attention | ADHD presentation | WM (frontal) |
| Adolescence | Executive function | Executive dysfunction | WM (frontal, CC) |
| 35–50 yr | Cardiovascular demand | Hypertension, early-onset CVD | Cardiac |
| 40–60 yr | Metabolic demand | Lean T2DM, metabolic syndrome | Pancreatic |
| 40–60 yr | Myelin maintenance | Accelerated cognitive decline | WM (lifetime OPC pool) |
| 50+ yr | Renal filtration | CKD, progressive renal failure | Renal |
White Matter Myelination Schedule
The last tract to reach peak maturity — the cingulum — peaks after age 40. The arcuate fasciculus, critical for complex syntax, is unmyelinated at birth.
| Tract | Function | At Birth | Peak Maturity | ASD Relevance |
|---|---|---|---|---|
| Corticospinal (CST) | Motor control | Early myelination | ~2 yr | Motor milestones, DCD |
| Arcuate fasciculus | Complex syntax | Unmyelinated | ~12–15 yr | Language delay — the key ASD tract |
| Corpus callosum (body) | Interhemispheric motor | Early myelination | ~35 yr | Speech motor coordination |
| Uncinate fasciculus | Word retrieval, social reward | Unmyelinated | ~30 yr | Social functioning |
| Fornix | Memory output | Early myelination | ~20 yr | Memory deficits |
| Cingulum | Emotional regulation | Early myelination | > 40 yr | Social-emotional deficits |
Ten “Idiopathic” Conditions Explained
The framework maps each condition to its gestational window and the age at which demand exceeds the stunted reserve.
| Condition | Systems | Window | Demand Spike Age |
|---|---|---|---|
| Essential hypertension | Renal + Cardiac | 20–38 wk | 35–50 yr |
| Lean T2DM | Pancreatic | 20–38 wk | 40–60 yr |
| Early-onset CVD | Cardiac | 20–38 wk | 40–50 yr |
| ADHD | WM (frontal) + Cortical | 23–32 wk | 5–12 yr |
| Reduced lung capacity | Pulmonary | 24–36 wk | Variable |
| TLE (temporal lobe epilepsy) | Hippocampal | 22–36 wk | Any age |
| DCD | WM + Cerebellar | 24–36 wk | 5–12 yr |
| Anxiety / Depression | Hippocampal + WM | 22–36 wk | Adolescence+ |
| CKDu (unknown origin) | Renal | 20–36 wk | 40–60 yr |
| Autoimmune conditions | Immune | 12–36 wk | Variable |
The Iron–PHD–HIF–OPC Convergence
At weeks 28–32, iron is simultaneously needed for four things:
Iron deficiency at this point = quadruple hit. 40–60% of pregnancies globally have suboptimal iron status. This is not a rare edge case — it is the default state for most of the world’s pregnancies.
Treatment Convergence
Eleven therapies — pharmacologically unrelated — all converge on the same two targets: oxygen delivery and OPC maturation.
| Therapy | O₂ Delivery | OPC Maturation | Timing |
|---|---|---|---|
| EPO / Darbepoetin | Prenatal–postnatal | ||
| Iron supplementation | Pre-conception onwards | ||
| Caffeine | From birth | ||
| Thyroid hormone (T3) | — | Prenatal–postnatal | |
| Clemastine | — | Postnatal (proposed) | |
| DHA / Omega-3 | — | Prenatal–postnatal | |
| MgSO₄ | — | Pre-delivery | |
| Exercise (maternal) | — | Prenatal | |
| HBOT | Postnatal | ||
| Music therapy | — | Postnatal | |
| UCB cells | Postnatal (experimental) |
6/11 target O₂ delivery. 9/11 target OPC maturation. 5/11 target both. Every trajectory points to the same axis.
Evidence Gaps & Testable Predictions
The framework generates falsifiable predictions. Every critical gap is named.
Critical gaps: No study directly measures myelination (not FA proxy) during autistic regression. No study demonstrates activity-dependent myelination from speech therapy in ASD. No confirmation of OPC maturation arrest as causal mechanism specifically in autism. Each link in the chain is individually supported. The complete chain has not been demonstrated in a single cohort.
45 documents. 19 extraction domains. One pathway. The framework doesn’t explain everything — but everything it does explain traces back to the same molecular axis: oxygen, HIF, iron, and the cells that build the wiring of the brain.